Condition or disease | Intervention/treatment | Phase |
---|---|---|
Atrial Fibrillation Paroxysmal Cardiac Arrythmias | Device: PVAC GOLD catheter ablation | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Care Provider, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients |
Actual Study Start Date : | June 29, 2017 |
Estimated Primary Completion Date : | October 28, 2019 |
Estimated Study Completion Date : | January 25, 2021 |
Arm | Intervention/treatment |
---|---|
No Intervention: Clinical Treatment Group | |
Experimental: Interventional Ablation Group |
Device: PVAC GOLD catheter ablation
Isolation of pulmonary veins using PVAC GOLD catheter.
|
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Association with the following characteristics:
Exclusion Criteria:
Contact: Mauricio I Scanavacca, MD, PhD | +55112661-5341 | mauricio.scanavacca@gmail.com | |
Contact: Luiz Claudio B Martins, MD | +5513974189969 | lcardio@uol.com.br |
Brazil | |
Arrhythmia Clinical Unit - Instituto do Coração - HCFMUSP | Recruiting |
Sao Paulo, SP, Brazil, 05403010 | |
Contact: Mauricio I Scanavacca, MD, PhD +551126615341 mauricio.scanavacca@gmail.com | |
Contact: Luiz Claudio B Martins, MD +5513974189969 lcardio@uol.com.br | |
Sub-Investigator: Luiz Claudio B Martins, MD | |
Sub-Investigator: Cristiano F Pisani, MD | |
Sub-Investigator: Carina A Hardy, MD | |
Sub-Investigator: Muhieddine O Chokr, MD | |
Sub-Investigator: Sissy L de Melo, MD | |
Sub-Investigator: Fabio K Dorfman, MD | |
Principal Investigator: Mauricio I Scanavacca, MD | |
Sub-Investigator: Francisco C Darrieux, MD | |
Sub-Investigator: Cesar J Grupi, MD | |
Sub-Investigator: Luciana Sacilotto, MD | |
Sub-Investigator: Denise T Hachul, MD | |
Sub-Investigator: Tam C Hu, MD | |
Sub-Investigator: Savia C Bueno, MD |
Principal Investigator: | Mauricio I Scanavacca, MD, PhD | Arrythmia Clinical Unit Director |
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | July 15, 2019 | ||||||||
First Posted Date ICMJE | July 17, 2019 | ||||||||
Last Update Posted Date | July 23, 2019 | ||||||||
Actual Study Start Date ICMJE | June 29, 2017 | ||||||||
Estimated Primary Completion Date | October 28, 2019 (Final data collection date for primary outcome measure) | ||||||||
Current Primary Outcome Measures ICMJE |
|
||||||||
Original Primary Outcome Measures ICMJE |
|
||||||||
Change History | |||||||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||||
Descriptive Information | |||||||||
Brief Title ICMJE | Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients | ||||||||
Official Title ICMJE | Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients | ||||||||
Brief Summary | It is a prospective, randomized and double-blind clinical trial involving an invasive technique for isolation of pulmonary veins (PVAC gold) in relation to clinical treatment during an one year of segment. The patients included have paroxysmal atrial fibrillation (aged 65 years and older) refractory to antiarrhythmic treatments that do not have structural and / or ischemic heart diseases. This trial employs quality of life scores prior to the study and during the sixth and twelfth month of the segment, electrocardiograms and holter of 24 hours. The proposed imaging tests will be the transesophageal echocardiogram before each procedure. The cerebral MRI will be performed in the 24 h post invasive procedure and Angio-tomography of the pulmonary veins in the 6-month segment. | ||||||||
Detailed Description | Not Provided | ||||||||
Study Type ICMJE | Interventional | ||||||||
Study Phase ICMJE | Phase 4 | ||||||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Care Provider, Outcomes Assessor) Primary Purpose: Treatment |
||||||||
Condition ICMJE |
|
||||||||
Intervention ICMJE | Device: PVAC GOLD catheter ablation
Isolation of pulmonary veins using PVAC GOLD catheter.
|
||||||||
Study Arms ICMJE |
|
||||||||
Publications * | Not Provided | ||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status ICMJE | Recruiting | ||||||||
Estimated Enrollment ICMJE |
60 | ||||||||
Original Estimated Enrollment ICMJE | Same as current | ||||||||
Estimated Study Completion Date ICMJE | January 25, 2021 | ||||||||
Estimated Primary Completion Date | October 28, 2019 (Final data collection date for primary outcome measure) | ||||||||
Eligibility Criteria ICMJE |
Inclusion Criteria:
Exclusion Criteria:
|
||||||||
Sex/Gender ICMJE |
|
||||||||
Ages ICMJE | 65 Years and older (Older Adult) | ||||||||
Accepts Healthy Volunteers ICMJE | No | ||||||||
Contacts ICMJE |
|
||||||||
Listed Location Countries ICMJE | Brazil | ||||||||
Removed Location Countries | |||||||||
Administrative Information | |||||||||
NCT Number ICMJE | NCT04023461 | ||||||||
Other Study ID Numbers ICMJE | 4471/16/137 | ||||||||
Has Data Monitoring Committee | No | ||||||||
U.S. FDA-regulated Product |
|
||||||||
IPD Sharing Statement ICMJE |
|
||||||||
Responsible Party | Mauricio Ibrahim Scanavacca, University of Sao Paulo General Hospital | ||||||||
Study Sponsor ICMJE | University of Sao Paulo General Hospital | ||||||||
Collaborators ICMJE | Medtronic | ||||||||
Investigators ICMJE |
|
||||||||
PRS Account | University of Sao Paulo General Hospital | ||||||||
Verification Date | July 2019 | ||||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |